98 related articles for article (PubMed ID: 18639570)
1. The in vivo rat muscle force model is a reliable and clinically relevant test of consistency among botulinum toxin preparations.
Pickett A; O'Keeffe R; Judge A; Dodd S
Toxicon; 2008 Sep; 52(3):455-64. PubMed ID: 18639570
[TBL] [Abstract][Full Text] [Related]
2. The effect of botulinum toxin type A injection on compound muscle action potential in an in vivo rat model.
Cichon JV; McCaffrey TV; Litchy WJ; Knops JL
Laryngoscope; 1995 Feb; 105(2):144-8. PubMed ID: 8544593
[TBL] [Abstract][Full Text] [Related]
3. Botulinum neurotoxin type A causes shifts in myosin heavy chain composition in muscle.
Dodd SL; Selsby J; Payne A; Judge A; Dott C
Toxicon; 2005 Aug; 46(2):196-203. PubMed ID: 15975617
[TBL] [Abstract][Full Text] [Related]
4. Quantitative determination of biological activity of botulinum toxins utilizing compound muscle action potentials (CMAP), and comparison of neuromuscular transmission blockage and muscle flaccidity among toxins.
Torii Y; Goto Y; Takahashi M; Ishida S; Harakawa T; Sakamoto T; Kaji R; Kozaki S; Ginnaga A
Toxicon; 2010; 55(2-3):407-14. PubMed ID: 19778548
[TBL] [Abstract][Full Text] [Related]
5. Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers.
Schroeder AS; Ertl-Wagner B; Britsch S; Schröder JM; Nikolin S; Weis J; Müller-Felber W; Koerte I; Stehr M; Berweck S; Borggraefe I; Heinen F
Mov Disord; 2009 Jul; 24(10):1494-503. PubMed ID: 19489066
[TBL] [Abstract][Full Text] [Related]
6. Effects of Botox and Neuronox on muscle force generation in mice.
Stone AV; Ma J; Whitlock PW; Koman LA; Smith TL; Smith BP; Callahan MF
J Orthop Res; 2007 Dec; 25(12):1658-64. PubMed ID: 17600825
[TBL] [Abstract][Full Text] [Related]
7. Mechano- and metabosensitive alterations after injection of botulinum toxin into gastrocnemius muscle.
Caron G; Rouzi T; Grelot L; Magalon G; Marqueste T; Decherchi P
J Neurosci Res; 2014 Jul; 92(7):904-14. PubMed ID: 24615939
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin for the management of adult patients with upper motor neuron syndrome.
Esquenazi A; Mayer NH; Elia AE; Albanese A
Toxicon; 2009 Oct; 54(5):634-8. PubMed ID: 19470335
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of therapeutic botulinum toxin preparations.
Dressler D; Benecke R
Disabil Rehabil; 2007 Dec; 29(23):1761-8. PubMed ID: 18033601
[TBL] [Abstract][Full Text] [Related]
10. Quantitative determination of the biological activity of botulinum toxin type A by measuring the compound muscle action potential (CMAP) in rats.
Sakamoto T; Torii Y; Takahashi M; Ishida S; Goto Y; Nakano H; Harakawa T; Ginnaga A; Kozaki S; Kaji R
Toxicon; 2009 Nov; 54(6):857-61. PubMed ID: 19559720
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin-induced focal paresis in mice is unaffected by muscle activity.
Kutschenko A; Reinert MC; Klinker F; Paulus W; Hesse S; Liebetanz D
Muscle Nerve; 2011 Dec; 44(6):930-6. PubMed ID: 22102464
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin injections as a method for chemically denervating skeletal muscle to test functional hypotheses: a pilot study in Lepomis cyanellus.
O'Neill MW; Gibb AC
Physiol Biochem Zool; 2007; 80(2):241-9. PubMed ID: 17252520
[TBL] [Abstract][Full Text] [Related]
13. Prediction of summation in incompletely fused tetanic contractions of rat muscle.
Macintosh BR; Jones D; Devrome AN; Rassier DE
J Biomech; 2007; 40(5):1066-72. PubMed ID: 16806237
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin injection causes hyper-reflexia and increased muscle stiffness of the triceps surae muscle in the rat.
Pingel J; Wienecke J; Lorentzen J; Nielsen JB
J Neurophysiol; 2016 Dec; 116(6):2615-2623. PubMed ID: 27628204
[TBL] [Abstract][Full Text] [Related]
15. Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment?
Wohlfarth K; Sycha T; Ranoux D; Naver H; Caird D
Curr Med Res Opin; 2009 Jul; 25(7):1573-84. PubMed ID: 19463043
[TBL] [Abstract][Full Text] [Related]
16. Mouse compound muscle action potential assay: an alternative method to conduct the LD₅₀ botulinum toxin type A potency test.
Kim SH; Kim SB; Yang GH; Rhee CH
Toxicon; 2012 Sep; 60(3):341-7. PubMed ID: 22613167
[TBL] [Abstract][Full Text] [Related]
17. Effects on craniofacial growth and development of unilateral botulinum neurotoxin injection into the masseter muscle.
Tsai CY; Chiu WC; Liao YH; Tsai CM
Am J Orthod Dentofacial Orthop; 2009 Feb; 135(2):142.e1-6; discussion 142-3. PubMed ID: 19201315
[TBL] [Abstract][Full Text] [Related]
18. The effects of botulinum toxin A on muscle histology during distraction osteogenesis.
Olabisi R; Chamberlain CS; Petr S; Steiner S; Consigny D; Best TM; Vanderby R; Schultz E; Noonan KJ
J Orthop Res; 2009 Mar; 27(3):310-7. PubMed ID: 18752291
[TBL] [Abstract][Full Text] [Related]
19. The Intercostal NMJ Assay: a new alternative to the conventional LD50 assay for the determination of the therapeutic potency of botulinum toxin preparations.
Huber A; France RM; Riccalton-Banks L; McLaren J; Cox H; Quirk RA; Shakesheff KM; Thompson D; Panjwani N; Shipley S; Pickett A
Altern Lab Anim; 2008 May; 36(2):141-52. PubMed ID: 18522482
[TBL] [Abstract][Full Text] [Related]
20. Dosage changes in patients with long-term botulinum toxin use for laryngeal dystonia.
Birkent H; Maronian N; Waugh P; Merati AL; Perkel D; Hillel AD
Otolaryngol Head Neck Surg; 2009 Jan; 140(1):43-7. PubMed ID: 19130960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
